The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro
In: Antiviral Research, Vol. 86 (2010), No. 3, pp. 312 - 315
2010article/chapter in journal
BiologyComputer ScienceMedicineFaculty of MedicineFaculty of Biology » Bioinformatics and Computational BiophysicsScientific institutes » Center of Medical Biotechnology (ZMB)
Title in English:
The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro
Author:
Drogan, Daniel;Rauch, Pia;Hoffmann, DanielUDE
- GND
- 1021044180
- GND
- 1214304125
- LSF ID
- 16263
- ORCID
-
0000-0003-2973-7869
- Other
- connected with university
Year of publication:
2010
PubMed ID
Scopus ID
Language of text:
English
Appears in
Title in English (abbreviated):
Antiviral Res
Place of publication:
Amsterdam
Publisher:
Elsevier
in:
Vol. 86 (2010), No. 3, pp. 312 - 315
ISSN
ISSN
ZDB ID
Keyword, Topic:
3TC ; Drug resistance ; Dual HIV-1 infection/competition model ; FTC ; HIV-1 ; M184V